Adello develops a programmatic mobile advertising platform intended to deliver exceptional accuracy in audience targeting. The Company offers an intelligent real-time targeting platform, that analyses petabytes of data and also provides audience targeting, campaign results, insights and self-learning campaigns, enabling enterprises to achieve brand and direct-response objectives in diverse industries including retail, cars and financial services.

Type
Private
HQ
San Francisco, US
Founded
2008
Size (employees)
40 (est)+12%
Website
adello.com
Adello was founded in 2008 and is headquartered in San Francisco, US
Report incorrect company information

Key People/Management at Adello

Bettina von Kupsch

Bettina von Kupsch

Board Member
Jan Stoess

Jan Stoess

VP Engineering
Bastian Kronenbitter

Bastian Kronenbitter

Head of Data Science
Ron Kwok

Ron Kwok

APAC Markets
Vanessa Marr

Vanessa Marr

VP Product
Dominique MeGret

Dominique MeGret

Advisor
Show more

Adello Office Locations

Adello has offices in Karlsruhe, San Francisco and Zürich
San Francisco, US (HQ)
548 Market St
Zürich, CH
31 Höschgasse
Show all (3)
Report incorrect company information

Adello Financials and Metrics

Summary Metrics

Founding Date

2008

Total Funding

$2 m

Time since last funding

10 months ago

Investors

Show all financial metrics
Report incorrect company information

Adello Online and Social Media Presence

Embed Graph
Report incorrect company information

Adello News and Updates

Neutropenia Market Key Players- Adello Biologics LLC, Apotex Inc, Arven Ilac and BeyondSpring Pharmaceuticals Inc Forecast byH1 2017-2022

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Neutropenia - Pipeline Review, H1 2017” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information